The indication of simultaneous genetic testing for BRCA1, BRCA2, and TP53 was recommended for women diagnosed with breast cancer at early onset who have a family history of cancer associated with LFS [35,36]. This evidence concerns the gene BRCA2 and breast carcinoma.